Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy

doi:10.4239/wjd.v13.i9.738

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4545)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

286

WORD

HTML

2567

Figures (1-1)

357

Tables (1-1)

284

Sum=3535

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

328

Download

682

Sum=1010

Sep 15, 2022 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Sep 15, 2022; 13(9): 738-751
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.738

Full Size Figure Download Figure

Figure 1 Immunological alterations in diabetes patients.

Citation: Vasilev G, Kabakchieva P, Miteva D, Batselova H, Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World J Diabetes 2022; 13(9): 738-751
URL: https://www.wjgnet.com/1948-9358/full/v13/i9/738.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i9.738